Pub Date : 2024-07-01DOI: 10.1177/03000605241258893
Bo Min, Yan Wang
Objective: The prognosis of lung adenocarcinoma (LUAD), which is the most common type of lung cancer, remains poor. Little is known about the function and mechanism of whey acidic protein four-disulfide core domain 2 (WFDC2) in LUAD.
Methods: In this study, we used online databases to compare WFDC2 expression between LUAD and normal tissues, to analyze the relationship between WFDC2 and overall survival, and to investigate the potential roles of WFDC2.
Results: We found that WFDC2 protein and mRNA expression levels were significantly higher in LUAD tissue than in normal tissue, and high WFDC2 mRNA expression was associated with better overall survival. WFDC2 mRNA expression was correlated with the mutation status of TP53. The biological function of WFDC2 was associated with the cell cycle, and low WFDC2 mRNA expression was associated with an elevated tumor mutational burden and neoantigen levels. A negative relationship was observed between WFDC2 and immune gene expression, and high WFDC2 mRNA expression was found in patients with LUAD and low programed cell death 1 mRNA expression.
Conclusions: We propose that WFDC2 is associated with clinical benefits of immune checkpoint inhibitors in LUAD.
{"title":"WFDC2 is a potential prognostic and immunotherapy biomarker in lung adenocarcinoma.","authors":"Bo Min, Yan Wang","doi":"10.1177/03000605241258893","DOIUrl":"10.1177/03000605241258893","url":null,"abstract":"<p><strong>Objective: </strong>The prognosis of lung adenocarcinoma (LUAD), which is the most common type of lung cancer, remains poor. Little is known about the function and mechanism of whey acidic protein four-disulfide core domain 2 (WFDC2) in LUAD.</p><p><strong>Methods: </strong>In this study, we used online databases to compare WFDC2 expression between LUAD and normal tissues, to analyze the relationship between WFDC2 and overall survival, and to investigate the potential roles of WFDC2.</p><p><strong>Results: </strong>We found that WFDC2 protein and mRNA expression levels were significantly higher in LUAD tissue than in normal tissue, and high WFDC2 mRNA expression was associated with better overall survival. WFDC2 mRNA expression was correlated with the mutation status of TP53. The biological function of WFDC2 was associated with the cell cycle, and low WFDC2 mRNA expression was associated with an elevated tumor mutational burden and neoantigen levels. A negative relationship was observed between WFDC2 and immune gene expression, and high WFDC2 mRNA expression was found in patients with LUAD and low programed cell death 1 mRNA expression.</p><p><strong>Conclusions: </strong>We propose that WFDC2 is associated with clinical benefits of immune checkpoint inhibitors in LUAD.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141788340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Haemorrhagic shock, which arises as a complication of pelvic fracture subsequent to severe trauma, represents a perilous state. The utilization of interventional endovascular haemostasis assumes a pivotal role in the management of patients with vascular injury following pelvic fracture. This article reports the treatment of a patient with pelvic fracture caused by a serious work-related vehicle accident. Despite the implementation of timely blood and fluid transfusion to combat shock, the application of aortic balloon obstruction, and interventional iliac artery embolization for haemostasis, the patient's condition failed to display any discernible improvement. Repeat angiography further revealed a displacement of the interventional embolization material, and the patient subsequently died of multiple organ failure. The occurrence of spring coil displacement is infrequent, but the consequences thereof are considered grave, necessitating meticulous discernment in the selection of haemostatic materials for this type of patient. The diagnostic and therapeutic processes encompassing the particular case described here were analysed and are discussed with the objective of augmenting the efficacy and success rate of treatment modalities for patients in similar circumstances.
{"title":"Spring coil displacement after interventional embolization of severe pelvic fracture: a case report.","authors":"Lijun Cao, Guoping Shen, Renyan Wu, Xuning Shen, Jun Xu, Hui Sun, Xianhua Xiang","doi":"10.1177/03000605241266219","DOIUrl":"10.1177/03000605241266219","url":null,"abstract":"<p><p>Haemorrhagic shock, which arises as a complication of pelvic fracture subsequent to severe trauma, represents a perilous state. The utilization of interventional endovascular haemostasis assumes a pivotal role in the management of patients with vascular injury following pelvic fracture. This article reports the treatment of a patient with pelvic fracture caused by a serious work-related vehicle accident. Despite the implementation of timely blood and fluid transfusion to combat shock, the application of aortic balloon obstruction, and interventional iliac artery embolization for haemostasis, the patient's condition failed to display any discernible improvement. Repeat angiography further revealed a displacement of the interventional embolization material, and the patient subsequently died of multiple organ failure. The occurrence of spring coil displacement is infrequent, but the consequences thereof are considered grave, necessitating meticulous discernment in the selection of haemostatic materials for this type of patient. The diagnostic and therapeutic processes encompassing the particular case described here were analysed and are discussed with the objective of augmenting the efficacy and success rate of treatment modalities for patients in similar circumstances.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11289803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141792674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-01DOI: 10.1177/03000605241260362
Abdullah M Alhammad, Ghada Alajmi, Aljawharah Alkhodair, Wael H Mansy, Mohammad H Aljawadi, Rania Aljadeed, Reem Alshammari, Raghad Alshehri, Mohammed N Alarifi, Badr Alyahya
Objective: In 2012, the Commission on Human Medicines mandated lowering the acetaminophen toxicity nomogram treatment threshold in the UK to 100 µg/ml at 4 h post-ingestion. The present study aim was to evaluate biochemical and liver toxicity patterns in patients who presented with acetaminophen overdose and had low serum acetaminophen concentrations (<150 µg/ml).
Methods: Patients admitted to the emergency department with a clear history of acute acetaminophen overdose with or without other medication or ethanol were consecutively enrolled into this retrospective cohort study. Patients with serum acetaminophen concentration >150 µg/ml or an unknown ingestion time were excluded. Data were extracted from electronic medical records and are presented as mean ± SD or median (interquartile range).
Results: A total of 103 patients were included (median age, 17 [4-21] years) and 80 (78%) were female. The median ingested acetaminophen dose was 5000 (2850-7650) mg. At baseline, the median serum acetaminophen concentration was 42 (4.5-64.8) µg/ml, and median alanine aminotransferase and aspartate aminotransferase levels were 22 (17-28) and 27 (16-45) IU/L, respectively. Twenty patients were treated with acetylcysteine, with none developing adverse reactions. No patient developed hepatotoxicity, including patients with initial multiple product ingestion or other risk factors.
Conclusions: Patients presenting with an acute acetaminophen overdose with acetaminophen level <150 µg/ml, including patients with other risk factors, are at low risk of hepatotoxicity.
{"title":"Patterns of acetaminophen toxicity among patients with low-risk serum concentrations.","authors":"Abdullah M Alhammad, Ghada Alajmi, Aljawharah Alkhodair, Wael H Mansy, Mohammad H Aljawadi, Rania Aljadeed, Reem Alshammari, Raghad Alshehri, Mohammed N Alarifi, Badr Alyahya","doi":"10.1177/03000605241260362","DOIUrl":"10.1177/03000605241260362","url":null,"abstract":"<p><strong>Objective: </strong>In 2012, the Commission on Human Medicines mandated lowering the acetaminophen toxicity nomogram treatment threshold in the UK to 100 µg/ml at 4 h post-ingestion. The present study aim was to evaluate biochemical and liver toxicity patterns in patients who presented with acetaminophen overdose and had low serum acetaminophen concentrations (<150 µg/ml).</p><p><strong>Methods: </strong>Patients admitted to the emergency department with a clear history of acute acetaminophen overdose with or without other medication or ethanol were consecutively enrolled into this retrospective cohort study. Patients with serum acetaminophen concentration >150 µg/ml or an unknown ingestion time were excluded. Data were extracted from electronic medical records and are presented as mean ± SD or median (interquartile range).</p><p><strong>Results: </strong>A total of 103 patients were included (median age, 17 [4-21] years) and 80 (78%) were female. The median ingested acetaminophen dose was 5000 (2850-7650) mg. At baseline, the median serum acetaminophen concentration was 42 (4.5-64.8) µg/ml, and median alanine aminotransferase and aspartate aminotransferase levels were 22 (17-28) and 27 (16-45) IU/L, respectively. Twenty patients were treated with acetylcysteine, with none developing adverse reactions. No patient developed hepatotoxicity, including patients with initial multiple product ingestion or other risk factors.</p><p><strong>Conclusions: </strong>Patients presenting with an acute acetaminophen overdose with acetaminophen level <150 µg/ml, including patients with other risk factors, are at low risk of hepatotoxicity.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287716/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141788335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-01DOI: 10.1177/03000605241258171
Fengjiao Zhu, Pengpeng Wang, Zhiyuan Zhang, Chunlei Yao, Yijie Wang, Juan Ye, Jian Wu
Objective: Apart from the role of the retinoblastoma gene, the genomic events associated with poor outcomes in patients with ophthalmic tumors are poorly understood.
Methods: We retrospectively analyzed 48 patients with six types of ophthalmic tumors. We searched for high-frequency mutated genes and susceptibility genes in these patients using combined exome and transcriptome analysis.
Results: We identified four clearly causative genes (TP53, PTCH1, SMO, BAP1). Susceptibility gene analysis identified hotspot genes, including RUNX1, APC, IDH2, and BRCA2, and high-frequency gene analysis identified several genes, including TP53, TTN, and MUC16. Transcriptome analysis identified 5868 differentially expressed genes, of which TOP2A and ZWINT were upregulated in all samples, while CFD, ELANE, HBA1, and HBB were downregulated. Kyoto Encyclopedia of Genes and Genomes enrichment analysis indicated that the phosphoinositide 3-kinase (PI3K)-Akt and Transcriptional misregulation in cancer signaling pathways may be involved in ophthalmic tumorigenesis.
Conclusions: TP53 is clearly involved in ophthalmic tumorigenesis, especially in basal cell carcinoma, and the PI3K-Akt signaling pathway may be an essential pathway involved in ophthalmic tumorigenesis. RUNX1, SMO, TOP2A, and ZWINT are also highly likely to be involved in ophthalmic tumorigenesis, but further functional experiments are needed to verify the mechanisms of these genes in regulating tumorigenesis.
{"title":"Integrative genomic analysis reveals cancer-associated mutations in patients with ophthalmic tumors.","authors":"Fengjiao Zhu, Pengpeng Wang, Zhiyuan Zhang, Chunlei Yao, Yijie Wang, Juan Ye, Jian Wu","doi":"10.1177/03000605241258171","DOIUrl":"10.1177/03000605241258171","url":null,"abstract":"<p><strong>Objective: </strong>Apart from the role of the retinoblastoma gene, the genomic events associated with poor outcomes in patients with ophthalmic tumors are poorly understood.</p><p><strong>Methods: </strong>We retrospectively analyzed 48 patients with six types of ophthalmic tumors. We searched for high-frequency mutated genes and susceptibility genes in these patients using combined exome and transcriptome analysis.</p><p><strong>Results: </strong>We identified four clearly causative genes (<i>TP53, PTCH1, SMO, BAP1</i>). Susceptibility gene analysis identified hotspot genes, including <i>RUNX1, APC, IDH2</i>, and <i>BRCA2</i>, and high-frequency gene analysis identified several genes, including <i>TP53, TTN</i>, and <i>MUC16</i>. Transcriptome analysis identified 5868 differentially expressed genes, of which <i>TOP2A</i> and <i>ZWINT</i> were upregulated in all samples, while <i>CFD</i>, <i>ELANE</i>, <i>HBA1</i>, and <i>HBB</i> were downregulated. Kyoto Encyclopedia of Genes and Genomes enrichment analysis indicated that the phosphoinositide 3-kinase (PI3K)-Akt and Transcriptional misregulation in cancer signaling pathways may be involved in ophthalmic tumorigenesis.</p><p><strong>Conclusions: </strong><i>TP53</i> is clearly involved in ophthalmic tumorigenesis, especially in basal cell carcinoma, and the PI3K-Akt signaling pathway may be an essential pathway involved in ophthalmic tumorigenesis. <i>RUNX1, SMO, TOP2A</i>, and <i>ZWINT</i> are also highly likely to be involved in ophthalmic tumorigenesis, but further functional experiments are needed to verify the mechanisms of these genes in regulating tumorigenesis.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11283671/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141759157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-01DOI: 10.1177/03000605241259655
Min Song, Hongtao Yuan, Jie Zhang, Jing Wang, Jianhua Yu, Wei Wang
Objective: This study aimed to identify significantly differentially expressed genes (DEGs) related to cervical cancer by exploring extensive gene expression datasets to unveil new therapeutic targets.
Methods: Gene expression profiles were extracted from the Gene Expression Omnibus, The Cancer Genome Atlas, and the Genotype-Tissue Expression platforms. A differential expression analysis identified DEGs in cervical cancer cases. Weighted gene co-expression network analysis (WGCNA) was implemented to locate genes closely linked to the clinical traits of diseases. Machine learning algorithms, including LASSO regression and the random forest algorithm, were applied to pinpoint key genes.
Results: The investigation successfully isolated DEGs pertinent to cervical cancer. Interleukin-24 was recognized as a pivotal gene via WGCNA and machine learning techniques. Experimental validations demonstrated that human interleukin (hIL)-24 inhibited proliferation, migration, and invasion, while promoting apoptosis, in SiHa and HeLa cervical cancer cells, affirming its role as a therapeutic target.
Conclusion: The multi-database analysis strategy employed herein emphasized hIL-24 as a principal gene in cervical cancer pathogenesis. The findings suggest hIL-24 as a promising candidate for targeted therapy, offering a potential avenue for innovative treatment modalities. This study enhances the understanding of molecular mechanisms of cervical cancer and aids in the pursuit of novel oncological therapies.
{"title":"Inhibitory effect of human interleukin-24 on the proliferation, migration, and invasion of cervical cancer cells.","authors":"Min Song, Hongtao Yuan, Jie Zhang, Jing Wang, Jianhua Yu, Wei Wang","doi":"10.1177/03000605241259655","DOIUrl":"10.1177/03000605241259655","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to identify significantly differentially expressed genes (DEGs) related to cervical cancer by exploring extensive gene expression datasets to unveil new therapeutic targets.</p><p><strong>Methods: </strong>Gene expression profiles were extracted from the Gene Expression Omnibus, The Cancer Genome Atlas, and the Genotype-Tissue Expression platforms. A differential expression analysis identified DEGs in cervical cancer cases. Weighted gene co-expression network analysis (WGCNA) was implemented to locate genes closely linked to the clinical traits of diseases. Machine learning algorithms, including LASSO regression and the random forest algorithm, were applied to pinpoint key genes.</p><p><strong>Results: </strong>The investigation successfully isolated DEGs pertinent to cervical cancer. Interleukin-24 was recognized as a pivotal gene via WGCNA and machine learning techniques. Experimental validations demonstrated that human interleukin (hIL)-24 inhibited proliferation, migration, and invasion, while promoting apoptosis, in SiHa and HeLa cervical cancer cells, affirming its role as a therapeutic target.</p><p><strong>Conclusion: </strong>The multi-database analysis strategy employed herein emphasized hIL-24 as a principal gene in cervical cancer pathogenesis. The findings suggest hIL-24 as a promising candidate for targeted therapy, offering a potential avenue for innovative treatment modalities. This study enhances the understanding of molecular mechanisms of cervical cancer and aids in the pursuit of novel oncological therapies.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141788289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To evaluate longitudinal changes in peripapillary vessel density (VD) following coronavirus disease 2019 (COVID-19) using optical coherence tomography angiography.
Methods: As part of a prospective longitudinal observational study, we studied healthy individuals with a history of mild COVID-19 confirmed via real-time polymerase chain reaction. After recovery, we used the Optovue RTVue XR Avanti machine to perform optic nerve head (ONH) imaging. We also assessed the VD of all vessels and of small vessels in the disc and the radial peripapillary capillary (RPC) network at 1 and 3 months post-recovery.
Results: We included 17 patients (34 eyes; mean age: 36.9 ± 10.2 years, range: 24-62 years) who had recovered from COVID-19. No changes were observed in the ONH parameters. However, there was a noticeable trend of increased small vessel VD values in the RPC. These increases were significant for the peripapillary whole, superior hemifield, inferior-temporal, temporal-superior, and superior-temporal small vessels. Moreover, the evaluation of all vessel VD values in the RPC revealed a significant decrease in the inside disc and a significant increase in a grid-based inferior region.
Conclusion: COVID-19 may affect VD of the RPC in the ONH, and should be considered in ONH evaluations.
{"title":"Optic nerve head alterations after COVID-19: an optical coherence tomography angiography-based longitudinal study.","authors":"Mojtaba Abrishami, Kiana Hassanpour, Kia Bayat, Seyedeh Maryam Hosseini, Nasibeh Amini, Majid Abrishami, Parham Sayyah Ensan, Hamid Reza Heidarzadeh","doi":"10.1177/03000605241263236","DOIUrl":"10.1177/03000605241263236","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate longitudinal changes in peripapillary vessel density (VD) following coronavirus disease 2019 (COVID-19) using optical coherence tomography angiography.</p><p><strong>Methods: </strong>As part of a prospective longitudinal observational study, we studied healthy individuals with a history of mild COVID-19 confirmed via real-time polymerase chain reaction. After recovery, we used the Optovue RTVue XR Avanti machine to perform optic nerve head (ONH) imaging. We also assessed the VD of all vessels and of small vessels in the disc and the radial peripapillary capillary (RPC) network at 1 and 3 months post-recovery.</p><p><strong>Results: </strong>We included 17 patients (34 eyes; mean age: 36.9 ± 10.2 years, range: 24-62 years) who had recovered from COVID-19. No changes were observed in the ONH parameters. However, there was a noticeable trend of increased small vessel VD values in the RPC. These increases were significant for the peripapillary whole, superior hemifield, inferior-temporal, temporal-superior, and superior-temporal small vessels. Moreover, the evaluation of all vessel VD values in the RPC revealed a significant decrease in the inside disc and a significant increase in a grid-based inferior region.</p><p><strong>Conclusion: </strong>COVID-19 may affect VD of the RPC in the ONH, and should be considered in ONH evaluations.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11295231/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-01DOI: 10.1177/03000605241266224
Lukas Fenkart, Rüdiger von Nitzsch, Esther Höggemann, Cord Spreckelsen
Objective: Value-focused thinking (VFT) is a decision-making method that places the qualitative elicitation of decisionmakers' objectives at the beginning of the decision-making process. A potential healthcare application of VFT is to elicit patients' objectives to better understand what matters to them. Only then can treatments be tailored accordingly. This is particularly important for patients with life-threatening diseases such as cancer. Thus, this interview study used VFT to elicit the life and treatment objectives of non-terminal oncologic inpatients.
Methods: Fifteen cancer inpatients (median age 66 years) were sampled in a German university hospital in September 2019. The participants completed questionnaires, the data of which were used to semi-structure the subsequent interviews. Data were analysed using inductive category formation to identify objectives in the transcribed interviews.
Results: Sixteen objectives in five life domains (optimising physical wellbeing, optimising mental wellbeing, optimising personal life, optimising family life and optimising financial life) were identified.
Conclusion: Comparison of the findings with previous research indicated that VFT is a reliable approach to elicit patients' objectives. The identified objectives could increase understanding of the outcomes that cancer inpatients care about.
{"title":"Using value-focused thinking to elicit oncologic inpatients' life and treatment objectives: a qualitative interview study.","authors":"Lukas Fenkart, Rüdiger von Nitzsch, Esther Höggemann, Cord Spreckelsen","doi":"10.1177/03000605241266224","DOIUrl":"10.1177/03000605241266224","url":null,"abstract":"<p><strong>Objective: </strong>Value-focused thinking (VFT) is a decision-making method that places the qualitative elicitation of decisionmakers' objectives at the beginning of the decision-making process. A potential healthcare application of VFT is to elicit patients' objectives to better understand what matters to them. Only then can treatments be tailored accordingly. This is particularly important for patients with life-threatening diseases such as cancer. Thus, this interview study used VFT to elicit the life and treatment objectives of non-terminal oncologic inpatients.</p><p><strong>Methods: </strong>Fifteen cancer inpatients (median age 66 years) were sampled in a German university hospital in September 2019. The participants completed questionnaires, the data of which were used to semi-structure the subsequent interviews. Data were analysed using inductive category formation to identify objectives in the transcribed interviews.</p><p><strong>Results: </strong>Sixteen objectives in five life domains (optimising physical wellbeing, optimising mental wellbeing, optimising personal life, optimising family life and optimising financial life) were identified.</p><p><strong>Conclusion: </strong>Comparison of the findings with previous research indicated that VFT is a reliable approach to elicit patients' objectives. The identified objectives could increase understanding of the outcomes that cancer inpatients care about.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11295223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: With mechanical thrombectomy (MT), we investigated the prognostic importance of aortic arch calcification (AoAC) and carotid sinus calcification (CaSC) for symptomatic intracerebral hemorrhage (sICH) and poor outcome in acute large artery occlusion (LAO).
Methods: In this retrospective observational study, we calculated pre-cranial artery calcification burden (PACB) scores (burden score of AoAC and CaSC) using the AoAC grading scale score plus Woodcock visual score. The outcome measure was sICH per the European Cooperative Acute Stroke Study III definition. A 3-month modified Rankin scale score 3-6 was designated as poor outcome.
Results: Compared with patients who had PACB <3, those with PACB ≥3 showed substantially higher risks of sICH (odds ratio [OR] = 2.567, 95% confidence interval [CI] = 1.187-5.550) and poor outcome (OR = 4.777, 95% CI = 1.659-13.756). According to receiver operating characteristic (ROC) curves, adding PACB to the regression model enhanced the predictive value for poor outcome (area under the ROC curve [AUC]: 0.718 vs. 0.519, Z = 2.340) and in patients receiving MT (AUC: 0.714 vs. 0.584, Z = 2.021), independently.
Conclusions: Factors related to PACB were consistent with common risk factors of systemic atherosclerosis. Low PACB scores indicated better prognosis. In patients with LAO following MT, PACB was useful in predicting sICH and poor clinical outcome.
目的:通过机械取栓术(MT),我们研究了主动脉弓钙化(AoAC)和颈动脉窦钙化(CaSC)对急性大动脉闭塞(LAO)症状性脑出血(sICH)和不良预后的重要性:在这项回顾性观察研究中,我们使用AoAC分级评分和Woodcock视觉评分计算了颅前动脉钙化负担(PACB)评分(AoAC和CaSC的负担评分)。根据欧洲急性卒中合作研究 III 的定义,结果指标为 sICH。3个月改良Rankin量表评分3-6分为不良预后:结论:与 PACB 患者相比,PACB 患者的预后较差:与 PACB 相关的因素与系统性动脉粥样硬化的常见风险因素一致。低 PACB 评分表明预后较好。在 MT 后 LAO 患者中,PACB 有助于预测 sICH 和不良临床预后。
{"title":"Precranial artery calcification burden: a potential indicator of the clinical outcome of reperfusion in patients with acute large artery occlusion.","authors":"Xiaofeng Cai, Dengfeng Zhou, Peng Wang, Zheyu Zhang, Yongmei Fan, Longting Lin, Yu Geng, Mahmud Mossa-Basha, Chengcheng Zhu, Sheng Zhang","doi":"10.1177/03000605241260364","DOIUrl":"10.1177/03000605241260364","url":null,"abstract":"<p><strong>Objective: </strong>With mechanical thrombectomy (MT), we investigated the prognostic importance of aortic arch calcification (AoAC) and carotid sinus calcification (CaSC) for symptomatic intracerebral hemorrhage (sICH) and poor outcome in acute large artery occlusion (LAO).</p><p><strong>Methods: </strong>In this retrospective observational study, we calculated pre-cranial artery calcification burden (PACB) scores (burden score of AoAC and CaSC) using the AoAC grading scale score plus Woodcock visual score. The outcome measure was sICH per the European Cooperative Acute Stroke Study III definition. A 3-month modified Rankin scale score 3-6 was designated as poor outcome.</p><p><strong>Results: </strong>Compared with patients who had PACB <3, those with PACB ≥3 showed substantially higher risks of sICH (odds ratio [OR] = 2.567, 95% confidence interval [CI] = 1.187-5.550) and poor outcome (OR = 4.777, 95% CI = 1.659-13.756). According to receiver operating characteristic (ROC) curves, adding PACB to the regression model enhanced the predictive value for poor outcome (area under the ROC curve [AUC]: 0.718 vs. 0.519, Z = 2.340) and in patients receiving MT (AUC: 0.714 vs. 0.584, Z = 2.021), independently.</p><p><strong>Conclusions: </strong>Factors related to PACB were consistent with common risk factors of systemic atherosclerosis. Low PACB scores indicated better prognosis. In patients with LAO following MT, PACB was useful in predicting sICH and poor clinical outcome.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287721/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141788336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-01DOI: 10.1177/03000605241259669
Yushi Ying, Hanning Li, Wenfei Xia, Teng Cheng, Hui Li, Qiang Fu, Tao Ai, Yan Yang, Ni Zhang, Xingrui Li, Qilin Ao, Yaying Du, Zhifang Yang
Parathyroid carcinoma (PC) is a rare and aggressive endocrine malignancy with limited treatment options. Current treatments such as chemotherapy and radiotherapy have demonstrated limited efficacy. Here, we report the case of a male patient who presented with symptoms including polydipsia, polyuria, and joint pain. Further examination revealed a neck lump, hypercalcemia, and hyperparathyroidism, leading to a diagnosis of PC after en bloc surgery. Seven months later, the patient developed local recurrence and lung metastases, which were resected via left lateral neck dissection and thoracoscopic wedge resection. A 422-gene panel test revealed the presence of epidermal growth factor receptor (EGFR) p.L858R (c. T2573G) mutation, which may sensitize the EGFR-tyrosine kinase inhibitor response, and phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA) p.E545KV (c. G1633A) mutation. After multidisciplinary treatment discussions, the patient was treated with the multi-target tyrosine kinase inhibitor, anlotinib, resulting in survival benefits for 19 months. This case highlights the potential of targeted therapy in terms of long-term survival in patients with distant metastatic PC, as well as the importance of precision therapy guided by genome sequencing to identify potential therapeutic targets.
甲状旁腺癌(PC)是一种罕见的侵袭性内分泌恶性肿瘤,治疗方案有限。目前的化疗和放疗等治疗方法疗效有限。在此,我们报告了一例男性患者的病例,该患者出现多尿、多饮和关节疼痛等症状。进一步检查发现患者颈部有肿块、高钙血症和甲状旁腺功能亢进,经过全切手术确诊为 PC。七个月后,患者出现局部复发和肺转移,经左侧颈部切除术和胸腔镜楔形切除术切除了肺转移灶。422个基因面板检测显示,患者存在表皮生长因子受体(EGFR)p.L858R(c. T2573G)突变和磷脂酰肌醇-4,5-二磷酸 3-激酶催化亚基α(PIK3CA)p.E545KV(c. G1633A)突变。经过多学科治疗讨论后,患者接受了多靶点酪氨酸激酶抑制剂安罗替尼的治疗,从而获得了长达19个月的生存期。该病例凸显了靶向治疗在远处转移性 PC 患者长期生存方面的潜力,以及在基因组测序指导下进行精准治疗以确定潜在治疗靶点的重要性。
{"title":"Long-term survival in a patient with metastatic parathyroid carcinoma harboring an <i>EGFR</i> sensitizing mutation: a case report.","authors":"Yushi Ying, Hanning Li, Wenfei Xia, Teng Cheng, Hui Li, Qiang Fu, Tao Ai, Yan Yang, Ni Zhang, Xingrui Li, Qilin Ao, Yaying Du, Zhifang Yang","doi":"10.1177/03000605241259669","DOIUrl":"10.1177/03000605241259669","url":null,"abstract":"<p><p>Parathyroid carcinoma (PC) is a rare and aggressive endocrine malignancy with limited treatment options. Current treatments such as chemotherapy and radiotherapy have demonstrated limited efficacy. Here, we report the case of a male patient who presented with symptoms including polydipsia, polyuria, and joint pain. Further examination revealed a neck lump, hypercalcemia, and hyperparathyroidism, leading to a diagnosis of PC after <i>en bloc</i> surgery. Seven months later, the patient developed local recurrence and lung metastases, which were resected via left lateral neck dissection and thoracoscopic wedge resection. A 422-gene panel test revealed the presence of epidermal growth factor receptor (<i>EGFR</i>) p.L858R (c. T2573G) mutation, which may sensitize the EGFR-tyrosine kinase inhibitor response, and phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (<i>PIK3CA</i>) p.E545KV (c. G1633A) mutation. After multidisciplinary treatment discussions, the patient was treated with the multi-target tyrosine kinase inhibitor, anlotinib, resulting in survival benefits for 19 months. This case highlights the potential of targeted therapy in terms of long-term survival in patients with distant metastatic PC, as well as the importance of precision therapy guided by genome sequencing to identify potential therapeutic targets.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11283662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141759158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-01DOI: 10.1177/03000605241262186
Jiheon Hong, Jonggeun Woo, Jeongwoo Jeon
Objective: Existing isokinetic contractions are characterized using standardized angular velocities, which can induce differing adaptations. Here, we characterized the variation in the isokinetic parameters of knee extensors according to individualized angular velocity (IAV).
Methods: We performed a cross-sectional study of 19 young, healthy men. We measured the maximum angular velocity (MAV) of concentric knee extension using the isotonic mode of an isokinetic dynamometer. Isometric and isokinetic (at angular velocities corresponding to 100%, 70%, 40%, and 10% of each individual's MAV) knee extensor contractions were performed, and the peak torque and mean power were recorded.
Results: Peak torque significantly decreased with increasing IAV (129.42 ± 25.04, 84.37 ± 20.97, and 56.42 ± 16.18 Nm at 40%, 70%, and 100%, respectively), except for isometric contraction (233.36 ± 47.85) and at 10% of MAV (208 ± 48.55). At the mean power, 10% of MAV (74.52 ± 20.84 W) was significantly lower than the faster IAV (176.32 ± 49.64, 161.53 ± 56.55, and 145.95 ± 50.64 W at 40%, 70%, and 100%, respectively), and 100% was significantly lower than 40%.
Conclusion: The optimized IAV for isokinetic contraction to improve power output while maintaining torque is 10% to 40% of MAV. IAV may reflect both the velocity and force components of power because individuals do not have the same angular velocity.
{"title":"Torque and power of knee extensor muscles at individualized isokinetic angular velocities.","authors":"Jiheon Hong, Jonggeun Woo, Jeongwoo Jeon","doi":"10.1177/03000605241262186","DOIUrl":"10.1177/03000605241262186","url":null,"abstract":"<p><strong>Objective: </strong>Existing isokinetic contractions are characterized using standardized angular velocities, which can induce differing adaptations. Here, we characterized the variation in the isokinetic parameters of knee extensors according to individualized angular velocity (IAV).</p><p><strong>Methods: </strong>We performed a cross-sectional study of 19 young, healthy men. We measured the maximum angular velocity (MAV) of concentric knee extension using the isotonic mode of an isokinetic dynamometer. Isometric and isokinetic (at angular velocities corresponding to 100%, 70%, 40%, and 10% of each individual's MAV) knee extensor contractions were performed, and the peak torque and mean power were recorded.</p><p><strong>Results: </strong>Peak torque significantly decreased with increasing IAV (129.42 ± 25.04, 84.37 ± 20.97, and 56.42 ± 16.18 Nm at 40%, 70%, and 100%, respectively), except for isometric contraction (233.36 ± 47.85) and at 10% of MAV (208 ± 48.55). At the mean power, 10% of MAV (74.52 ± 20.84 W) was significantly lower than the faster IAV (176.32 ± 49.64, 161.53 ± 56.55, and 145.95 ± 50.64 W at 40%, 70%, and 100%, respectively), and 100% was significantly lower than 40%.</p><p><strong>Conclusion: </strong>The optimized IAV for isokinetic contraction to improve power output while maintaining torque is 10% to 40% of MAV. IAV may reflect both the velocity and force components of power because individuals do not have the same angular velocity.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11283666/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141759160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}